Integrated DNA Technologies and Beckman Coulter Life Sciences partner to advance cancer research
Collaboration aims to equip users with complete NGS solution from sample to answer
Collaboration aims to equip users with complete NGS solution from sample to answer
Test will serve as a companion diagnostic for Bayer’s HYRNUO™ (sevabertinib) to identify patients with non-small cell lung cancer eligible for HER2-targeted therapy
The project will generate 830 GWh of clean electricity annually, powering over 440,000 homes and reducing 166,549 tons of CO₂ emissions
New generation of allergen tests to support faster, more accurate diagnosis worldwide
Felicity Solar joins ENF Trade TV discussion on LFP vs sodium-ion batteries amid global energy storage surge
A study from Karl Landsteiner University of Health Sciences demonstrates HIFU effectively controls prostate cancer and maintains patients’ quality of life.
Findings from the study reveal how a repair system inside some bacteria plays a pivotal role in helping them survive commonly-used antibiotics
Acquisition strengthens QIAGEN’s presence in the rapidly growing single-cell market
Clearance expands menu and enables high-sensitivity troponin I measurement to aid in the diagnosis of myocardial infarction
An interdisciplinary effort to revolutionize imaging of early mammalian development through next-generation intravital microscopy
Third consecutive project demonstrates performance advantages of synthetic binders in therapeutic development applications
Partnership with Solve Scientific strengthens international sales as part of ongoing global expansion
Offers UK academic research institutions improved access to Primerdesign’s real-time PCR assays and reagents with reliable, fast and local support
AI tools are boosting productivity, but researchers raise concerns about trust and transparency in answers, representing a missed opportunity for R&D
A Queensland University of Technology collaborated resource merging scientific insight with practical laboratory methods
The kit as broad coverage for influenza strains, emerging SARS-CoV-2 variants, and detection of both RSV subgroups A and B
Collaboration between UpNano and Husun Technologies brings 2PP 3D-printing to one of the world’s largest technology markets
Acquisition to include Red One™ solid-phase cytometry platform for rapid sterility and bioburden testing, which expands Lonza’s portfolio of automated, scalable solutions for pharmaceutical quality control
Tuznue is a biosimilar of Herceptin (trastuzumab), developed to offer a more cost-effective therapeutic alternative for patients
New dengue antigen test delivers high clinical sensitivity and specificity, as well as inclusivity for all four dengue virus serotypes, helping clinicians distinguish dengue from other acute fever-causing illnesses